Is This MedTech Start-Up The Next Hundred-Billion Cardio Breakthrough Stock?

The HEART is one of the final frontiers of human health. It’s why cardiologists can easily earn $400,000 a year . . . and even now, when the organ fails, it’s the top cause of death for men and women alike.

Part of the mystery revolves around the structure of the heart itself. It’s a muscle that runs on a complicated storm of electricity, basically a living, organic pacemaker. When the cardiologist can read the signals, the heart goes on.

Because there’s a lot of noise on the monitor, it’s still as much art as science. That’s why BioSig Technologies (NASDAQ:BSGM) has spent years building a better heart monitor . . . which is now being deployed in places like the Mayo Clinic.

We’re starting to hear early anecdotes about how much heart surgeons appreciate a clearer view of the mysterious organ that keeps us all alive. For investors, …View the full post at: Is This MedTech Start-Up The Next Hundred-Billion Cardio Breakthrough Stock?

Related Articles:

Cannabis: This is the Hottest CBD Market Trend of 2019

The Top Cannabis Stocks with a Powerful Colombian Market Catalyst

These 3 Top Cannabis Stocks are Dominating the Market

Three CBD Stocks Well Positioned to Profit from the 2018 Farm Bill